The New York Blood Center's Milstein Cord Blood Program is proud to acknowledge the nomination of its first-in-class hematopoietic stem cell product, HEMACORD for the 2013 "Best Biotechnology Product" Award by Prix Galien USA.
http://www.freshnews.com/news/826444/hemacord-first-fda-licensed-stem-cell-product-nominated-prix-galien-usa-best-biotechnol
http://www.freshnews.com/news/826444/hemacord-first-fda-licensed-stem-cell-product-nominated-prix-galien-usa-best-biotechnol
No comments:
Post a Comment